Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

Takashi Eguchi

Visiting Investigator

Start Year

2014

Scholarships

Shinshu University Research Scholarship Research Scholarship

Publications

Manuscripts

Abstracts/Presentations

  • Eguchi T, Bains S, Tan KS, Bains MS, Downey RJ, Huang J, Isbell JM, Park BJ, Rusch VW, Jones DR, Adusumilli PS. Impact of increasing age on cause-specific mortality and morbidity in stage I NSCLC patients: A competing risk analysis. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Eguchi T, Kameda K, Lu S, Bott M, Tan KS, Jones DR, Travis WD, Adusumilli PS. In early-stage lung adenocarcinomas, survival by tumor size (T) is further stratified by tumor spread through air spaces. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Lee M-C, Eguchi T, Tano Z, Kadota K, Jones DR, Adusumilli PS. Tumoral IL-7 receptor is a potential target for lung adenocarcinoma immunotherapy. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Tan KS, Eguchi T, Adusumilli PS. Quantifying survival in early-stage NSCLC: implications of relative survival vs cause-specific survival. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Takahashi Y, Eguchi T, Lu S, Downey RJ, Jones DR, Travis WD, Adusumilli PS. Histological subtyping of matched primary and metastases sites in lung adenocarcinoma: Significance of solid predominance. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Lu S, Eguchi T, Isbell JM, Tan KS, Jones DR, Travis WD, Adusumilli PS. Clinicopathological significance of increasing percentage of high-grade histological subtypes in lung adenocarcinomas. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • LuS, Eguchi T, Zachery Tano, Molena D, Jones DR, Travis WD, Adusumilli PS. Comparative histological subtype analysis of lung adenocarcinoma tumor and metastatic lymph nodes and the prognostic impact. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Lu S, Eguchi T, Tan KS, Bains S, Kadota K, Rekhtman N, Adusumilli PS, Travis WD. Tumor spread through air spaces (STAS) in lung squamous cell cancer is an independent risk factor: A competing risk analysis. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Kameda K, Lu S, Eguchi T, Rekhtman N, Huang J, Chang JC, Montecalvo J, Jones DR, Travis WD, Adusumilli PS. Can tumor spread through air spaces (STAS) in lung adenocarcinomas be predicted pre- and intraoperatively? International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Bains S, Eguchi T, Warth A, Yeh Y-C, Nitadori J-I, Woo KM, Chou T-Y, Dienemann H, Muley T, Nakajima J, Shinozaki-Ushiku A, Wu Y-C, Kadota K, Travis WD, Tan KS, Jones DR, Adusumilli PS. A multi-national cohort validation of procedure–specific nomograms to predict recurrence for small lung adenocarcinomas. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Eguchi T, Lu S, Zeltsman M, Chaft JE, Travis WD, Jones DR, Adusumilli PS. Solid histological subtype predicts benefit from adjuvant chemotherapy in resected stage II-III lung adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Takahashi Y, Eguchi T, Lu S, Molena D, Travis WD, Jones DR, Adusumilli PS. N2a1, clinicopathological significance of single station skip metastases: Investigation of Proposal for 8th Edition of TNM. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Eguchi T, Kameda K, Lu S, Tano Z, Huang J, Jones DR, Adusumilli PS, Travis WD. Implications of 8th Edition TNM Proposal: Invasive vs. total size for T descriptor in pT1a-2bN0M0 lung adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Kameda K, Eguchi T, Lu S, Solomon S, Bott M, Rekhtman N, Jones DR, Travis WD, Adusumilli PS. Preoperative needle biopsy and tumor spread through alveolar spaces (STAS) in resected lung adenocarcinomas. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Takahashi Y, Eguchi T, Tan KS, Lu S, Travis WD, Jones DR, Adusumilli PS. Occult nodal metastasis in clinical stage I lung adenocarcinoma (LADC): Incidence, sites and risk regression analysis. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Hristov B, Eguchi T, Isbell JM, Park BJ, Tan KS, Rusch VW, Jones DR, Adusumilli PS. Minimally invasive lobectomy is associated with lower noncancer mortality in elderly: A propensity-score matched analysis. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Zeltsman M, Poch A, Eguchi T, Bains S, Park BJ, Jones DR, Adusumilli PS. Decreasing use of epidural analgesia with increasing minimally invasive lobectomy: Impact on postoperative morbidity. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Tan KS, Eguchi T, Adusumilli PS. Appropriate endpoint for stage I NSCLC: correlations of long-term survival with disease-free and recurrence-free survival. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Tan KS, Eguchi T, Adusumilli PS. Comparability of the relative survival metrics among lung cancer patients and general population. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Lu S, Rekhtman N, Eguchi T, Jones DR, Adusumilli PS, Travis WD. Cases Demonstrating Spread Through Air Spaces (STAS) Reflects Invasive Growth and Not an Artifact. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Hristov B, Eguchi T, Chintala N, Lu S, Bott M, Travis WD, Jones DR, Adusumilli PS. Immunotherapy for KRAS positive lung adenocarcinoma: Mesothelin and CA125 (MUC16) are cancer-antigen targets. International Association for the Study of Lung Cancer (IASLC) 17th World Conference on Lung Cancer. December 4-7, 2016; Vienna, Austria.
  • Adusumilli P, Bueno R, Cerfolio R, Harpole Jr. D, Eguchi T, Lu S, Gustafson C, Calloway S, Joshi MB, Evans B, Hughes E, Yager K, Sibley A, Jones JT, Hartman AR. Elevated Expression of Cell Cycle Progression Genes is Associated with Absolute Chemotherapy Benefit in Early Stage Lung Adenocarcinoma Patients. 2016 American Society of Clinical Oncology Annual Meeting. June 3-7, 2016; Chicago, Illinois.
  • Lu S, Tan KS, Kadota K, Eguchi T, Bains S, Adusumilli P, Travis W. Spread Through Air Spaces (STAS) is an Independent Predictor of Recurrence in Lung Squamous Cell Carcinoma. 2016 United States & Canadian Academy of Pathology Annual Meeting. March 12-18, 2016; Seattle, WA.
  • Eguchi T, Ujiie H, Morello A, Kadota K, Buitrago DH, Woo K, Jones DR, Travis WD, Sadelain M, Adusumilli PS. Mesothelin and MUC16 (CA125) Are Antigen-Targets for CAR T-Cell Therapy in Primary and Metastatic Lung Adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Eguchi T, Kadota K, Rizk NP, Woo KM, Sima CS, Park BJ, Jones DR, Travis WD, Adusumilli PS. T1a Lung Adenocarcinomas: Presence of Spread of Tumor through Alveolar Spaces (STAS), Micropapillary and Solid Patterns Determines Outcomes International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Eguchi T, Buitrago DH, Mayor M, Kadota K, Rizk NP, Park BJ, Jones DR, Adusumilli PS. Long and Short-Term Predictors of Outcome in Elderly Patients (≥ 75 Years) Undergoing Lobectomy for Stage I Non-Small Cell Lung Cancer. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Eguchi T, Kadota K, Leduc C, Rekhtman N, Moreira A, Jones DR, Adusumilli PS. HNF4α Is a Marker for Invasive Mucinous Adenocarcinoma (IMA) and a Prognostic Factor in Stage I Lung Adenocarcinoma (LADC). International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Ujiie H, Eguchi T, Mayor M, Kadota K, Travis WD, Jones DR, Sadelain M, Adusumilli PS. Targetable Cancer-Associated Antigens for Immunotherapy in Malignant Pleural Mesothelioma (MPM) - Mesothelin, CA125 and WT-1. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Adusumilli PS, Eguchi T. Validation of a cell cycle progression score for 5-year mortality risk in patients with stage I non-small cell lung cancer. 2015 American Society of Clinical Oncology Annual Meeting. May 29-June 2, 2015; Chicago, IL.
  • Chauhan C, Buitrago D, Eguchi T, Adusumilli PS. Comorbidities and cancer-specific outcomes in younger and elderly patients following resection for Stage I non-small cell lung cancer. 37th Annual Memorial Sloan-Kettering Cancer Center Medical Student Summer Fellowship Program Poster Presentation. August 8, 2014; New York, NY.